Clinical Research Directory
Browse clinical research sites, groups, and studies.
Expression of Stress Markers During Meth Treatment (EXPRESS+)
Sponsor: University of California, Los Angeles
Summary
This is a non-randomized behavioral trial that aims to investigate whether changes in inflammatory and type I IFN expression coincide with changes in methamphetamine use and viral load over the course of 12 weeks in HIV-positive people assigned male at birth with and without methamphetamine use disorder.
Official title: Expression of Stress Markers in MSM Living With HIV Receiving Contingency Management for Methamphetamine Use Disorder
Key Details
Gender
MALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
55
Start Date
2022-09-01
Completion Date
2026-03-31
Last Updated
2024-05-07
Healthy Volunteers
Yes
Conditions
Interventions
Contingency Management
A positive reinforcement behavioral treatment with escalating rewards for consecutive negative urine tests, starting at $10 and capped at a maximum of $40 per negative result.
Locations (1)
UCLA Vine Street Clinic
Los Angeles, California, United States